My opinion, the market is inefficient at the biotech small cap end. IXC coverage is low and risk reward is in our favour. Unappreciated and uncovered = opportunity and that’s why I am here coupled with I like the asset and it’s opportunity.
But to be fair, this is going to be a long cold winter for IXC.
The news flow will be negligible for 1.5 years. Limited surprises. Limited updates.
I have the patience to get set, plant the money and leave it be but most don’t I feel.
This will bounce around the base for some time to come.
SP ripples before the wave.
My opinion, the market is inefficient at the biotech small cap...
Add IXC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
7.2¢ |
Change
0.000(0.00%) |
Mkt cap ! $5.411M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 158 | 7.4¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 8.0¢ | 5000 | 1 |
View Market Depth
| Last trade - 16.12pm 29/07/2024 (20 minute delay) ? |
| IXC (ASX) Chart |
Day chart unavailable